TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE

QR Code

TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE

Information on the toxicological and pharmacological characteristics of the main excipients used in the formulation of torasemide (sodium croscarmellose, microcrystalline cellulose, magnesium stearate, pregelatinized corn starch, silica, mannitol) is presented in the article.

Saved in:

Bibliographic Details
Main Authors:	D. Yu. Ivkin, A. A. Teslev, A. S. Dziuba, A. S. Ivkina
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	torasemide excipient generic safety toxicity pharmaceutical development
Online Access:	https://www.pharmjournal.ru/jour/article/view/544
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interchangeability of Fluconazole Drugs
by: N. D. Bunyatyan, et al.
Published: (2018-12-01)

The Use of Plant-Derived Biomaterials as Drug Formulation Excipients: An Application of Biomimetics in Dosage Form Development
by: Omobolanle Ayoyinka Omoteso, et al.
Published: (2024-05-01)

Torasemide – loop diuretic with specific effects
by: V. M. Gorbunov, et al.
Published: (2006-10-01)

INFLUENCE OF TORASEMIDE ON ELECTRICAL INSTABILITY OF THE HEART IN PATIENTS WITH ISCHEMIC MITRAL REGURGITATION POST MYOCARDIAL INFARCTION
by: I. B. Ibragimova, et al.
Published: (2018-04-01)

TORASEMIDE IN PREVENTION OF MITRAL REGURGITATION AND CHRONIC HEART FAILURE WORSENING IN POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2018-06-01)

Study of the Influence of Pharmaceutical Excipients on the Solubility and Permeability of BCS Class II Drugs
by: Vivien Bárdos, et al.
Published: (2025-04-01)

Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition
by: V. I. Kocherovets, et al.
Published: (2021-10-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide
by: N. M. Gafurova, et al.
Published: (2021-03-01)

GELS FOR ORAL ADMINISTRATION. PART 2. EXCIPIENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY
by: H. H. Shugushev, et al.
Published: (2016-01-01)

EXCIPIENTS IN ORAL SUSPENSIONS
by: V. V. Vernikovsky, et al.
Published: (2019-01-01)

Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01)

Interchangeability of Essential Phospholipid Products
by: N. D. Bunyatyan, et al.
Published: (2019-12-01)

THE IMPORTANCE OF CHROMATOGRAPHICALLY PURIFIED EXCIPIENTS
by: G. J. Rizzo, et al.
Published: (2019-01-01)

Multifunctional investigation of “drug–excipient unification” of natural polysaccharide nanocarriers: A new paradigm from drug delivery to adjuvant therapy
by: Huan Yang, et al.
Published: (2025-09-01)

Ranking mAb–excipient interactions in biologics formulations by NMR spectroscopy and computational approaches
by: Chunting Zhang, et al.
Published: (2023-12-01)

Justification of the choice of excipients during the development of the composition of “Pastinocard” tablets
by: N. А. Symonenko, et al.
Published: (2023-11-01)

Original drugs and generics: are there any differences from the clinician’s point of view?
by: S. Yu. Martsevich, et al.
Published: (2024-10-01)

Influence of Excipients and Pressing Force on the Impurity Content of N-(4-aminobenzoyl)-L-glutamic Acid in Folic Acid Drugs During Storage
by: N. A. Obraztsova, et al.
Published: (2023-05-01)

Derivatografic study of the ointment with piroctone olamine for therapy and prevention of seborrheic dermatitis
by: V. A. Solodovnyk, et al.
Published: (2020-08-01)

Effects of the high-molecular excipients on optimization of the pharmacokinetic properties of drugs
by: P. . Bochkov, et al.
Published: (2020-04-01)

Study of the technological properties of excipients in the development of the composition of orally dispersible tablets
by: I. D. Kasymov, et al.
Published: (2021-12-01)

The choice of auxiliary substances to obtain sublingual glycin tablets with thiotriazoline with direct compaction method Reporting 1. Study of the influence of excipients on the bulk density, the bulk density after shrinkage, the fluidity and the angle o
by: L. I. Kucherenko, et al.
Published: (2020-05-01)

APPROACHES TO THE SELECTION OF EXCIPIENTS FOR DENTAL GEL WITH CETYLPYRIDINIUM CHLORIDE
by: E. Yu. Zagorulko, et al.
Published: (2021-06-01)

Investigation of excipients’ nature influence on the quality indices of effervescent tablets of acetylsalicylic acid, paracetamol and ascorbic acid
by: О. V. Tryhubchak, et al.
Published: (2018-03-01)

Role and Safety of Excipients in Syrups (Review)
by: V. V. Kosenko, et al.
Published: (2025-05-01)

CHARACTERIZATION AND PHARMACEUTICAL EVALUATION OF DAUCUS CAROTA PECTIN AS A SUSPENDING AGENT IN ORAL DOSAGE FORMS
by: Frederick William Akuffo Owusu, et al.
Published: (2024-03-01)

Organoids pharmacology and toxicology
by: Jie Sun, et al.
Published: (2025-09-01)

THE ANALYSIS OF THE PHARMACEUTICAL MARKET ON THE EXAMPLE OF MEDICINES OF GROUP OF INHIBITORS OF THE PROTON POMP
by: N. V. Mazova, et al.
Published: (2019-01-01)

Pengaruh Variasi Disintegran Avicel PH-102 dan Primogel terhadap Karakteristik Co-Processed Excipient
by: Hilya Nur Imtihani, et al.
Published: (2023-03-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01)

Toxicological parameters of the drug based on Ornidazole and Levamisole hydrochloride
by: A. V. Butenko, et al.
Published: (2023-01-01)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)

Toxicological characteristics of dental gel ‘Matripin’
by: L. I. Arystan, et al.
Published: (2020-11-01)

Development of Compositions and Technologies for Producing Tablets with Hydroxythyrozol-standardized Extract of Olive Leaves
by: M. S. Maslennikova, et al.
Published: (2021-08-01)

Toxicity Removal of Pharmaceuticals Mixtures through Electron Beam Irradiation
by: NAthalia Fonseca Boiani, et al.
Published: (2022-12-01)

Economic challenges of oncological diseases’ pharmacotherapy
by: E. A. Ushkalova, et al.
Published: (2020-04-01)

Excipients choice justification for the creation of Adamantane-1ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate tablets by the method of wet granulation (part 2)
by: V. M. Odyntsova, et al.
Published: (2017-08-01)